Synaptogenix Inc

NASDAQ:SNPX  
8.07
+0.07 (+0.88%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Synaptogenix Inc Stock, NASDAQ:SNPX

1185 Avenue of the Americas, 3rd floor, New York, New York 10036
Phone: +1.973.242.0005
Number of Employees:

Description

Synaptogenix, Inc. operates as a biopharmaceutical company. It develops a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimerâ??s disease, which is in the clinical testing stage. The firm also evaluates potential therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions. The company was founded on October 31, 2012 and is headquartered in New York, NY.